全球虛擬臨床試驗市場規模、佔有率、成長分析、按適應症、按研究設計 - 產業預測，2024-2031 年

Global Virtual Clinical Trials Market Size, Share, Growth Analysis, By Indication(Oncology, Cardiovascular), By Study Design(Interventional, Observational) - Industry Forecast 2024-2031

出版日期: 2024年03月10日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球虛擬臨床試驗市場規模為82.4億美元，從2023年的87.1億美元成長到2031年的136.3億美元，預測期間（2024-2031年）複合年成長率為5.75%。

全球數位醫療基礎設施的日益普及是市場成長的關鍵驅動力。虛擬臨床試驗 (VCT) 在皮膚病學測試中的日益普及進一步推動了市場擴張。遠距臨床測試通常用於評估不需要複雜測試的皮膚病。隨著全球冠狀病毒感染疾病(COVID-19) 大流行的持續，對虛擬和遠端測試解決方案的需求大幅增加，以確保安全有效的資料收集。此外，虛擬患者互動平台的採用和穿戴式技術的整合等技術進步也是成長的催化劑。這些技術透過遠端醫療平台推動，有助於連接患者和醫療保健提供者。然而，缺乏指導方針以及管理傳入資訊的需求可能會阻礙市場成長。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東/非洲
- 海灣合作理事會國家
- 南非
- 其他中東/非洲地區

競爭格局

前5名企業對比
主要企業市場定位（2021年）
主要市場參與者所採取的策略
關鍵成功策略
近期市集活動
主要企業市場佔有率（2021年）

主要企業簡介

IQVIA Holdings Inc.
科文斯公司（LabCorp 的子公司）
PRA Health Sciences Inc.
Medidata Solutions Inc.（達梭系統公司的子公司）
Parexel International Corporation（潘普洛納資本管理公司的子公司）
Oracle Corporation
Clinipace Worldwide
Medable Inc.
THREAD Research Inc.
Science 37 Inc.
Veeva Systems Inc.
Florence Healthcare
Clinerion Ltd.
Evidation Health Inc.
Transparency Life Sciences
Reify Health Inc.
Illingworth Research Group Ltd.
Circuit Clinical Inc.
Antidote Technologies Inc.
Aktana Inc.

簡介目錄

Product Code: SQMIG35D2037

Global Virtual Clinical Trials Market size was valued at USD 8.24 billion in 2022 and is poised to grow from USD 8.71 billion in 2023 to USD 13.63 billion by 2031, growing at a CAGR of 5.75% during the forecast period (2024- 2031).

The increasing adoption of digital healthcare infrastructure globally is a key driver of market growth. The expanded utilization of virtual clinical trials (VCT) for dermatology testing is further fueling market expansion. Remote trials are commonly employed to assess skin conditions that do not necessitate complex examinations. With the ongoing spread of the coronavirus disease (COVID-19) worldwide, there has been a notable surge in demand for virtual and remote testing solutions to ensure safe and effective data collection. Additionally, technological advancements such as the introduction of virtual patient interaction platforms and the integration of wearable technologies are serving as catalysts for growth. These technologies, facilitated through telemedicine platforms, aid in connecting patients with healthcare providers. However, the absence of guidelines and the need to manage the influx of information may hinder market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Virtual Clinical Trials Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Virtual Clinical Trials Market Segmental Analysis

Global virtual clinical trials market is segmented on the basis of indication, study design, and region. By indication, global market is segmented into oncology, cardiovascular and other. By study design, global market is segmented into, Interventional, observational and expanded access. By region, global market is divided into North America, Europe, Asia Pacific, Latin America, and MEA.

Drivers of the Global Virtual Clinical Trials Market

Real-time reporting and data collection are significant factors driving market growth. A notable shift involves the direct transfer of data from smartphones or wearables into the clinical database, eliminating the need for clinical trial staff to manually input data from different documents, which may result in potential data loss or editing errors. This streamlined process enhances data accuracy and integrity. Additionally, involving a diverse range of participants contributes to richer and higher-quality data.

Restraints in the Global Virtual Clinical Trials Market

Data security is a significant concern that impedes the growth of the global virtual clinical trials market. Patients' confidential medical data is transmitted directly over the Internet, making it vulnerable to hacking or unauthorized access. Sponsors are required to inform all participants of this potential risk in the informed consent form. In the event of a data breach, there must be a clear plan in place to address the issue and notify participants and trial sponsors promptly.

Market Trends of the Global Virtual Clinical Trials Market

A virtual clinical trial offers an alternative approach to traditional clinical trials, leveraging new connected devices to enhance clinical data collection, analysis, and interpretation. Various digital tools such as clinical trial monitoring devices, clinical trial software, eCOA, ePRO, and eConsent are employed to facilitate clinical trial activities. The "bring-your-own-devices" strategy, widely embraced by CROs and sponsors, enables participants to utilize their Internet-enabled solutions to provide the necessary data. Technological advancements and increased confidence in research outcomes are driving the exploration of new solutions. A recent retrospective approach utilizing synthetic clinical trials has emerged as a significant development in the virtual clinical trials market, expected to experience substantial growth. Additionally, the integration of artificial intelligence (AI) in clinical trials is transforming the trial process by accelerating target validation, clinical trial design, and patient identification for participation in virtual clinical trials.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Virtual Clinical Trials Market by Indication

Market Overview
Oncology
Cardiovascular
other

Global Virtual Clinical Trials Market by Study Design

Market Overview
Interventional
Observational
Expanded access

Global Virtual Clinical Trials Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

IQVIA Holdings Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Covance Inc. (a subsidiary of LabCorp)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PRA Health Sciences Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medidata Solutions Inc. (a subsidiary of Dassault SystA¨mes)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Parexel International Corporation (a subsidiary of Pamplona Capital Management)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Oracle Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Clinipace Worldwide
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medable Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
THREAD Research Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Science 37 Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Veeva Systems Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Florence Healthcare
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Clinerion Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Evidation Health Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Transparency Life Sciences
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Reify Health Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Illingworth Research Group Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Circuit Clinical Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Antidote Technologies Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aktana Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments